Volume 19, Issue 5 (8-2016)                   J Arak Uni Med Sci 2016, 19(5): 86-91 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nourbakhsh P, Merzaei R, Yeganeh-Fard F, Mosayebi G. Serum Level of Chemerin in Patients with Breast Cancer. J Arak Uni Med Sci 2016; 19 (5) :86-91
URL: http://jams.arakmu.ac.ir/article-1-4281-en.html
1- Department of Immunology and Microbiology, Arak University of Meical Sciences, Arak, Iran.
2- Student Research Committee, Arak University of Medical Sciences, Arak, Iran.
3- Molecular and Medicine Research Center (MMRC), Department of Immunology and Microbiology, Arak University of Medical Sciences, Arak, Iran. , gmosayebi@yahoo.com
Abstract:   (4832 Views)

Background: Breast cancer is one of the major causes of cancer-related death and the most common solid malignancy in women worldwide. Chemerin as a new adipokine has an inflammatory activity that initiates inflammation via chemotaxis of immature DCs and macrophages. This study aimed to evaluate the level of chemerin in patients with breast cancer.

Materials and Methods: In this cross-sectional study that was performed as a case-control study, we enrolled 45 patients with breast cancer in Vali-asr hospital from June to December 2015 (age range, 18-60 years) and 40 healthy volunteers as a control group (age range, 22-56 years). The patients with invasive breast were selected before mastectomy. The level of serum chemerin was measured by ELISA kit.

Results: The results showed that the mean serum chemerin level in the breast cancer patients (1536 ±608 ng/L) was significantly lower than the normal individuals (1919±544 ng/L),(p=0.04). There is no correlation between the level of chemerin with body weight, stage of disease, duration of disease and the number of white and red blood cells.

Conclusion: With due attention to the inflammatory role of chemerin, decreasing the serum chemerin level in patients with breast cancer may be related to the consumption of chemerin in the inflammatory responses or immunosuppression by tumor. The low level of chemrerin may be suitable for tumor growth and progression.

Full-Text [PDF 507 kb]   (1680 Downloads)    
Type of Study: Original Atricle | Subject: Internal
Received: 2016/03/3 | Accepted: 2016/05/18

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb